General form of registration statement for all companies including face-amount certificate companies

Assets Purchase Agreements (Details)

v3.24.4
Assets Purchase Agreements (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 27, 2024
USD ($)
May 13, 2024
item
Jul. 28, 2023
USD ($)
Jul. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Assets Purchase Agreements                    
Proceeds from the sale of property and equipment             $ 0 $ 6,000 $ 6,000 $ 127
Gain on sale of property and equipment         $ 0 $ 1,351 0 $ 1,351 1,466  
Property, plant and equipment, held for sale         $ 2,209   2,209   $ 0  
June 2024 Repurchase of Assets                    
Assets Purchase Agreements                    
Purchase price $ 1,400                  
Upfront payment $ 100     $ 100            
Upfront payment, due period from Effective Date 5 days                  
Subsequent payment $ 1,300           $ 1,300      
Subsequent amount, due period from closing date 12 months                  
Amount of net assets below this threshold, the Company may elect to delay payment obligation by additional six months $ 20,000                  
Extension term for deferred payment 6 months                  
Interest rate on outstanding Deferred Amount 5.00%                  
Rate of interest accrual on Deferred Amount not paid in full after 12 months 12 months                  
Amount of net receivables to forgive under Asset Purchase Agreement $ 3,300                  
Outstanding receivables 6,900                  
Outstanding payables 3,600                  
Total purchase consideration 4,700                  
Fair value provided from valuation services less costs to sell 2,200                  
Purchase consideration allocated to the supplies repurchased 2,500                  
Supplies repurchased with no alternate future use recognized as research and development expense 2,200                  
Supplies repurchased with alternate future use recognized as research and development expense 300                  
Property, plant and equipment, held for sale $ 2,200                  
uBriGene                    
Assets Purchase Agreements                    
Proceeds from the sale of property and equipment     $ 6,000              
Gain on sale of property and equipment     1,400              
Sale consideration considered deferred income     $ 300              
Number of parties obligated to terminate agreements | item   2                
Equipment assets purchased term   180 days